Accessibility Information

Users of assistive technologies such as screen readers should use the following link to activate Accessibility Mode before continuing: Learn more and Activate accessibility mode.

Autonomous Diagnostics to Enable Prevention and Therapeutics: Prophylactic Options to Environmental and Contagious Threats (ADEPT-PROTECT)

Solicitation Number: DARPA-BAA-13-03
Agency: Other Defense Agencies
Office: Defense Advanced Research Projects Agency
Location: Contracts Management Office
  • Print


There have been modifications to this notice. You are currently viewing the original synopsis. To view the most recent modification/amendment, click here
Added: Nov 01, 2012 3:15 pm
DARPA is soliciting proposals for the development of nucleic acid platforms capable of in vivo host production of a transient immune prophylaxis for adults as a component of the Autonomous Diagnostics to Enable Prevention and Therapeutics (ADEPT) program.

See attached DARPA-BAA-13-03.

Please consult the list of document viewers if you cannot open a file.


Other (Draft RFPs/RFIs, Responses to Questions, etc..)
Posted Date:
November 1, 2012
Description: DARPA-BAA-13-03
675 North Randolph Street
Arlington, Virginia 22203-2114
United States
Daniel Wattendorf,